These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 563741)

  • 1. Small doses of apomorphine and chronic administration of d-amphetamine reduce locomotor hyperactivity produced by radiofrequency lesions of dopaminergic A10 neurons area.
    Stinus L; Gaffori O; Simon H; Le Moal M
    Biol Psychiatry; 1977 Dec; 12(6):719-32. PubMed ID: 563741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locomotor hyperactivity and hypoexploration after lesion of the dopaminergic-A10 area in the ventral mesencephalic tegmentum (VMT) of rats.
    Gaffori O; Le Moal M; Stinus L
    Behav Brain Res; 1980 Aug; 1(4):313-29. PubMed ID: 7295380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
    Jeziorski M; White FJ
    Synapse; 1989; 4(4):267-80. PubMed ID: 2603146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinsonian motor deficits are reflected by proportional A9/A10 dopamine neuron degeneration in the rat.
    Moore AE; Cicchetti F; Hennen J; Isacson O
    Exp Neurol; 2001 Dec; 172(2):363-76. PubMed ID: 11716560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kainic acid induced lesion of ventral tegmental area: locomotor effect of apomorphine.
    Morgenstern R
    Acta Biol Med Ger; 1980; 39(8-9):911-5. PubMed ID: 7282221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for selective involvement of dopamine D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of D-amphetamine.
    Bjijou Y; Stinus L; Le Moal M; Cador M
    J Pharmacol Exp Ther; 1996 May; 277(2):1177-87. PubMed ID: 8627530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dopaminergic A10 neurons and frontal system (author's transl)].
    Simon H
    J Physiol (Paris); 1981 Apr; 77(1):81-95. PubMed ID: 6785426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration.
    Henry DJ; Greene MA; White FJ
    J Pharmacol Exp Ther; 1989 Dec; 251(3):833-9. PubMed ID: 2557418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-dependent effects of antidepressant drugs on the low dose of apomorphine-induced locomotor hypoactivity in rats.
    Dziedzicka-Wasylewska M; Rogóz Z
    Pol J Pharmacol; 1997; 49(5):337-43. PubMed ID: 9566033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological evidence for A10 dopamine autoreceptor subsensitivity following chronic D-amphetamine treatment.
    White FJ; Wang RY
    Brain Res; 1984 Sep; 309(2):283-92. PubMed ID: 6478223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral effects of a lesion in the ventral mesencephalic tegmentum: evidence for involvement of A10 dopaminergic neurons.
    Le Moal M; Stinus L; Simon H; Tassin JP; Thierry AM; Blanc G; Glowinski J; Cardo B
    Adv Biochem Psychopharmacol; 1977; 16():237-45. PubMed ID: 883544
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute and chronic administration of the selective D(3) receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Ashby CR; Minabe Y; Stemp G; Hagan JJ; Middlemiss DN
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1166-74. PubMed ID: 10945873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylphenidate and amphetamine modulate differently the NMDA and AMPA glutamatergic transmission of dopaminergic neurons in the ventral tegmental area.
    Prieto-Gómez B; Vázquez-Alvarez AM; Martínez-Peña JL; Reyes-Vázquez C; Yang PB; Dafny N
    Life Sci; 2005 Jun; 77(6):635-49. PubMed ID: 15921995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microiontophoretic studies.
    White FJ; Wang RY
    J Pharmacol Exp Ther; 1984 Nov; 231(2):275-80. PubMed ID: 6491980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine.
    Kalivas PW; Weber B
    J Pharmacol Exp Ther; 1988 Jun; 245(3):1095-102. PubMed ID: 3385638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of PD 118717, a putative piperazinyl benzopyranone dopamine autoreceptor agonist.
    Pugsley TA; Christofferson CL; Corbin A; DeWald HA; Demattos S; Meltzer LT; Myers SL; Shih YH; Whetzel SZ; Wiley JN
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1147-58. PubMed ID: 1361570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robust sensitization to amphetamine following intra-VTA cholera toxin administration.
    Byrnes JJ; Weinstein DM; Wallace LJ
    Synapse; 1997 Apr; 25(4):335-44. PubMed ID: 9097392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies.
    Wachtel SR; White FJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):410-6. PubMed ID: 2891845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area.
    Latimer LG; Duffy P; Kalivas PW
    J Pharmacol Exp Ther; 1987 Apr; 241(1):328-37. PubMed ID: 3033208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.